Cambrian Bio to boost aging pipeline with Amplifier Therapeutics launch
Cambrian Bio, a clinical-stage biotechnology company focused on treating and preventing chronic diseases of aging,…
March 15, 2023 - 2 minutes
Kidney disease
Calliditas shares rise as phase 3 endpoints met in kidney disease trial
Swedish company Calliditas Therapeutics AB has announced positive topline results from the global, randomized, double-blind,…
March 14, 2023 - 4 minutes
5 advancements in kidney disease research over the past year
Prevalent in millions of people across the globe, kidney diseases manifest through various symptoms like…
March 9, 2023 - 7 minutes
Orbsen Therapeutics happy with interim diabetic kidney disease study results
Orbsen Therapeutics Limited has announced what it says are encouraging headline interim results from the…
January 26, 2023 - 3 minutes
New therapy transitions toxic immune cells from harmful to healing to fight effects of hyperinflammation in children
When we think about acute kidney injury (AKI) and multi-organ failure, we don’t often think…
November 14, 2022 - 5 minutes
Early diagnosis tool for childhood kidney disease
Early diagnosis of chronic kidney disease (CKD) is key to managing progression of the disease.…
November 14, 2022 - 4 minutes
EMPA-KIDNEY trial meets primary endpoint in trial for drug to treat chronic kidney disease
A phase 3 clinical trial, EMPA-KIDNEY, met its primary endpoint showing a significant kidney and…
November 4, 2022 - 4 minutes
New drug application for chronic kidney disease sparks $35M milestone payment
A submission has been made for a new drug application by Japanese Kyowa Kirin Co.…
October 31, 2022 - 3 minutes
Rila Therapeutics exits stealth mode to address renal fibrosis
Rila Therapeutics, a biotherapeutics company focused on addressing the critical unmet medical needs to treat…
October 28, 2022 - 3 minutes
The hottest private biotech companies in Australia
Australia has a strong base in biotechnology, with many incentives for R&D and commercialization. Here…
October 18, 2022 - 5 minutes
Poxel granted orphan drug designation for kidney disease treatment
French biopharma company Poxel SA says the U.S. Food and Drug Administration (FDA) has granted…
October 3, 2022 - 2 minutes
Everest Medicines gets go-ahead for renal disease drug study
Chinese biopharma company Everest Medicines says the China National Medical Products Administration (NMPA)'s Center for…
September 26, 2022 - 2 minutes
